BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30609327)

  • 21. [The Construction of Reference Laboratory in Japan].
    Araki H
    Rinsho Byori; 2016 May; 64(5):539-543. PubMed ID: 30695364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Laboratory Medicine and Medical Team Approaches--Opening Remarks from the Chair].
    Suwabe A; Yoneyama A
    Rinsho Byori; 2014 Nov; 62(11):1135-6. PubMed ID: 27509735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Case Conference of Hematological Malignancies Based on the Morphology of Blood Cells: Chairmen's Introductory Remarks].
    Inaba T; Ikemoto T
    Rinsho Byori; 2016 Nov; 64(11):1310-1312. PubMed ID: 30695313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Utilization of Multi-Institutional Laboratory Data as an Evidence Database: The Current Status and Future Tasks--Chairmen's Introductory Remarks].
    Miyake K; Nishibori M
    Rinsho Byori; 2015 Jan; 63(1):127-8. PubMed ID: 26524889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Countermeasures against patient misidentification in laboratory study--chairmen's introductory remarks].
    Shimetani N; Yoshida H
    Rinsho Byori; 2013 Aug; 61(8):737-8. PubMed ID: 24218773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Laboratory and Team-Based Medicine--From the Standpoint of JSLM].
    Matsuo S
    Rinsho Byori; 2014 Nov; 62(11):1151-4. PubMed ID: 27509738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ["How can hospitals develop a beneficial relationship with laboratory testing companies?" - Chairmen's introductory remarks].
    Morita T; Kawano S
    Rinsho Byori; 2014 Dec; 62(12):1245-6. PubMed ID: 25823241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The Latest Findings in Liver Diseases -Chairman's Introductory Remarks.].
    Ikeda H
    Rinsho Byori; 2016 May; 64(4):463-464. PubMed ID: 29182819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Case conference of hematological malignancies based on the morphology of blood cells: chairmen's introductory remarks].
    Inaba T; Tohyama K
    Rinsho Byori; 2014 Jul; 62(7):699-701. PubMed ID: 25669040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Quality of Human Liquid Specimens Appropriate for Laboratory Tests and Analyses--Chairmen's Introductory Remarks].
    Furuta K; MaekawA M
    Rinsho Byori; 2015 Jan; 63(1):94-6. PubMed ID: 26524884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanism Causing Abnormal Laboratory Data--Significance of Electrophoresis and Information Transmission--Chairmen's Introductory Remarks].
    Maekawa M; Fujita K
    Rinsho Byori; 2014 Nov; 62(11):1072-3. PubMed ID: 27509723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Activities for laboratory medicine support after the Great East Japan Earthquake by the Japanese Society of Laboratory Medicine].
    Sakamoto H; Goto K; Nagasawa M; Ohana N; Okuda Y; Yamada O; Yamazaki I; Kobayashi T; Goda T; Nokoshimatsu N; Minowa M; Suwabe A; Shimetani N
    Rinsho Byori; 2011 Dec; 59(12):1144-53. PubMed ID: 22338917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current state and the future of medical technologist as a specialist Japanese Association of Medical Technologists].
    Nagasako T; Kawashima T; Takada T
    Rinsho Byori; 2012 Jun; 60(6):576-8. PubMed ID: 22880237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transition of Japanese societies related to clinical chemistry in the mid-Showa period (1955-1980) (part 3) - related to the medical field].
    Yamada M
    Yakushigaku Zasshi; 2002; 37(1):95-9. PubMed ID: 12412605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Postgraduates' training as laboratory physicians/clinical pathologists in Japan--board certification of JSLM as a mandatory requirement for chairpersons of laboratory medicine].
    Kumasaka K
    Rinsho Byori; 2002 Apr; 50(4):353-7. PubMed ID: 12014013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Quality control survey implemented by Japan Medical Association and standardization of external quality assessment in Japan].
    Kawano K
    Rinsho Byori; 2001 Sep; 49(9):860-3. PubMed ID: 11685771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Standardization of clinical laboratory data in Japan by the JAMT and JCCLS].
    Hosogaya S
    Rinsho Byori; 2009 Jun; 57(6):579-83. PubMed ID: 19621792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Etiology of Secondary Hyperlipidemia and Abnormalities of Lipid Laboratory Tests -Chairmen's Introductory Remarks -].
    Yoshida H; Miida T
    Rinsho Byori; 2016 May; 64(5):506-507. PubMed ID: 30695358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [ISO 15189 accreditation and future perspectives-Chairmen's introductory remarks].
    Kayamori Y; Takagi Y
    Rinsho Byori; 2012 Jul; 60(7):650-2. PubMed ID: 22973725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.